Download F2008L02617 F2008L02617

COMMONWEALTH OF AUSTRALIA
Instrument number PB 78 of 2008
Determination under subsections 85A(1) and (2) and 88(1C) of the
National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department
of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under
subsections 85A(1) and (2) and 88(1C) of the National Health Act 1953.
Dated
9th July
2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Determination — Prescription of pharmaceutical benefits by authorised
Optometrists
1
Commencement
This instrument commences on 1 August 2008.
2
Repeal
Instrument number PB 10 of 2008 is repealed.
3
Definition
In this instrument:
Act means the National Health Act 1953.
4
Form allowable
For subsection 85A(1) of the Act, the form of a pharmaceutical benefit
mentioned in an item of Schedule 1 that is allowable for prescription by an
authorised optometrist is the form mentioned in the description of the
pharmaceutical benefit in the item.
Note More than 1 form may have been determined for a pharmaceutical benefit , in which
case each form is allowable for prescription: see Acts Interpretation Act 1901, para 23 (b).
5
Maximum quantity or number of units
(1)
For paragraph 85A (2) (a) of the Act, the maximum quantity or number of
units of a pharmaceutical benefit mentioned in an item of Schedule 1 that an
authorised optometrist may, in 1 prescription, direct to be supplied on any 1
occasion, either for all purposes or for a particular purpose (if any) mentioned
in the item, is the quantity or number of units mentioned in the item.
(2)
For this section, the maximum quantity of a pharmaceutical benefit mentioned
in an item in Schedule 1 is in the form mentioned in the description of the
pharmaceutical benefit in the item.
Note A pharmaceutical benefit may or may not have a pharmaceutical item. The description of
a pharmaceutical benefit in an individual item of Schedule 1 makes it clear whether the item
relates to a pharmaceutical benefit that has a pharmaceutical item or not.
6
Maximum number of repeats
For paragraph 85A (2) (b) of the Act, the maximum number of occasions
for which an authorised optometrist may, in 1 prescription, direct that the
supply of a pharmaceutical benefit mentioned in an item of Schedule 1 be
repeated, either for all purposes or for a particular purpose (if any) mentioned
in the item, is the number mentioned in the item.
7
Manner of administration
For paragraph 85A (2) (c) of the Act, the manner of administration of a
pharmaceutical benefit mentioned in an item of Schedule 1 that an authorised
optometrist may, in a prescription, direct to be used is the manner of
administration mentioned in the description of the pharmaceutical benefit in
the item.
Instrument Number PB 78 of 2008
2
8
Pharmaceutical benefits that may be prescribed by authorised
optometrists
For subsection 88 (1C) of the Act, an authorised optometrist is authorised to
write a prescription for the supply of a pharmaceutical benefit that is
mentioned in Schedule 1.
9
Particular purpose of supply of a pharmaceutical benefit
For sections 4 and 5, if there are any particular purposes for which the
supply of a pharmaceutical benefit may be directed:
(a)
those purposes are identified by the purpose code in the item of
Schedule 1 dealing with the particular pharmaceutical benefit; and
(b)
the purpose that the purpose code stands for is set out in the lower part
of the item.
Instrument Number PB 78 of 2008
3
SCHEDULE 1
MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS
BY AUTHORISED OPTOMETRISTS
(sections 3 to 7)
Pharmaceutical Benefit
Listed drug
Purposes of Supply
Form
Manner of
administration
Brand
For all purposes (other
than a particular purpose)
Maximum
quantity or
number
Maximum
repeats
Aciclovir
Eye ointment 30 mg per g, 4.5 g
Application to the eye
Zovirax
1
..
Carbomer 974
Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30
Application to the eye
Poly Gel
3
5
Carbomer 980
Ocular lubricating gel 2 mg per g, 10 g
Application to the eye
GelTears
1
5
PAA
Viscotears Liquid Gel
Carmellose
Chloramphenicol
Eye drops 2 mg per g, single dose units 0.6 mL, 30
Application to the eye
Viscotears
3
5
Eye drops containing carmellose sodium 5 mg per mL, 15 mL
Application to the eye
Refresh Tears Plus
1
5
Eye drops containing carmellose sodium 10 mg per mL, 15 mL
Application to the eye
Refresh Liquigel
1
5
Eye drops containing carmellose sodium 2.5 mg per mL, single dose units
0.6 mL, 24
Application to the eye
TheraTears
4
5
Eye drops containing carmellose sodium 5 mg per mL, single dose units
0.4 mL, 30
Application to the eye
Cellufresh
3
5
Eye drops containing carmellose sodium 10 mg per mL, single dose units
0.4 mL, 30
Application to the eye
Celluvisc
3
5
Ocular lubricating gel containing carmellose sodium 10 mg per mL, single
dose units 0.6 mL, 28
Application to the eye
TheraTears
3
5
Eye drops 5 mg per mL, 10 mL
Application to the eye
Chloromycetin
1
2
1
..
1
5
1
..
1
..
Chlorsig
Eye ointment 10 mg per g, 4 g
Application to the eye
Chloromycetin
Chlorsig
Cromoglycic Acid
Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL
Application to the eye
Cromolux
Opticrom
Fluorometholone
Eye drops 1 mg per mL, 5 mL
Application to the eye
Flucon
FML Liquifilm
Flurbiprofen
Eye drops containing flurbiprofen sodium 300 micrograms per mL, single
dose units 0.4 mL, 5
Application to the eye
Instrument Number PB 78 of 2008
4
Ocufen
For particular purposes
(purpose code followed by
quantity or number)
Maximum
Maximum
quantity or
repeats
number
SCHEDULE 1
MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS
BY AUTHORISED OPTOMETRISTS — continued
Pharmaceutical Benefit
Listed drug
Purposes of Supply
Form
Manner of
administration
Brand
For all purposes (other
than a particular purpose)
Maximum
quantity or
number
Hydrocortisone
Hypromellose
Maximum
repeats
Eye ointment containing hydrocortisone acetate 5 mg per g, 5 g
Application to the eye
Hycor
1
..
Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g
Application to the eye
Hycor
1
..
Eye drops 3 mg per mL, 15 mL
Application to the eye
Genteal
1
5
In a Wink Moisturising
Eye drops 5 mg per mL, 15 mL
Application to the eye
Methopt
1
5
Hypromellose with
Carbomer 980
Ocular lubricating gel 3 mg-2 mg per g, 10 g
Application to the eye
Genteal gel
1
5
Hypromellose with
Dextran
Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL,
15 mL
Application to the eye
1
5
Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL,
single dose units 0.4 mL, 28
Application to the eye
Bion Tears
3
5
Eye ointment, compound, containing white soft paraffin with liquid paraffin,
3.5 g
Application to the eye
Duratears
2
5
Pack containing 2 tubes eye ointment, compound, containing white soft
paraffin with liquid paraffin, 3.5 g
Application to the eye
1
5
Eye drops 4 mg-3 mg per mL, 15 mL
Application to the eye
Systane
1
5
Eye drops 4 mg-3 mg per mL, single dose units 0.7 mL, 28
Application to the eye
Systane
3
5
Eye drops 14 mg per mL, 15 mL
Application to the eye
Liquifilm Tears
1
5
Paraffin
HPMC PAA
Poly-Tears
Tears Naturale
Poly Visc
Ircal
Lacri-Lube
Poly Visc
Polyethylene Glycol 400
with Propylene Glycol
Polyvinyl Alcohol
PVA Tears
Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen
peroxide as preservative)
Application to the eye
Vistil
1
5
Eye drops 30 mg per mL, 15 mL
Application to the eye
Liquifilm Forte
1
5
PVA Forte
Instrument Number PB 78 of 2008
5
For particular purposes
(purpose code followed by
quantity or number)
Maximum
Maximum
quantity or
repeats
number
SCHEDULE 1
MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS
BY AUTHORISED OPTOMETRISTS — continued
Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen
peroxide as preservative)
Application to the eye
Vistil Forte
1
5
Sulfacetamide
Eye drops containing sulfacetamide sodium 100 mg per mL, 15 mL
Application to the eye
Bleph 10
1
2
Tamarindus indica seed
polysaccharide
Eye drops 10 mg per mL, 0.5 mL, 20
Application to the eye
Visine Professional
3
5
Instrument Number PB 78 of 2008
6